Indication
NTSR1-expressing solid tumors
1 clinical trial
2 products
Product
[225]-FPI-2059Clinical trial
A Phase 1 Study of [225Ac]-FPI-2059 in Adult Participants With NTSR1-Expressing Advanced, Metastatic and/or Recurrent Solid TumoursStatus: Recruiting, Estimated PCD: 2025-06-01
Product
[111In]-FPI-2058